180
Pharmacology – Pot- pourri Peggy Andrews, Instructor Chemeketa CC

Pharmacology – Pot-pourri

  • Upload
    kaida

  • View
    31

  • Download
    3

Embed Size (px)

DESCRIPTION

Pharmacology – Pot-pourri. Peggy Andrews, Instructor Chemeketa CC. Analgesics. Opiates & Opiate Blockers. Buprenex Stadol Vicodin Demerol Morphine sulfate Fentanyl. Nubain Trexan Narcan. We’ll talk about. Buprenex buprenorphine. Class Opioid analgesic (agonist – antagonist) - PowerPoint PPT Presentation

Citation preview

Page 1: Pharmacology – Pot-pourri

Pharmacology – Pot-pourri

Peggy Andrews, Instructor

Chemeketa CC

Page 2: Pharmacology – Pot-pourri

Analgesics

Page 3: Pharmacology – Pot-pourri

Opiates & Opiate Blockers

Page 4: Pharmacology – Pot-pourri

We’ll talk about• Buprenex• Stadol• Vicodin• Demerol• Morphine

sulfate• Fentanyl

• Nubain • Trexan• Narcan

Page 5: Pharmacology – Pot-pourri

Buprenexbuprenorphine

• Class– Opioid analgesic (agonist –

antagonist)– Schedule V

• Indications– Management of moderate to

severe pain

Page 6: Pharmacology – Pot-pourri

• Action– Binds to opiate receptors in

CNS (30x morphine and 3x narcan)

– Alters perception of and response to pain

– Produces generalized CNS depression

Page 7: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Increased ICP

• Adverse reactions, SE– Nausea/Vomiting– Dizzyness– Headache– Confusion– Dysphoria– Sedation– Sweating

Page 8: Pharmacology – Pot-pourri

•Route & dosage– IV, 0.3 mg q 4-6 h prn

•How supplied– 0.3 mg/ml in 1 ml

preload

Page 9: Pharmacology – Pot-pourri

Stadol butorphanol tartrate

• Class– Opioid analgesic

(agonist/antagonist)• Indications

– Management of moderate to severe pain

– Analgesic during labor

Page 10: Pharmacology – Pot-pourri

• Action– Binds to opiate

receptors in CNS– Alters perception of

response to painful stimuli

• Contraindications– Hypersensitivity– Opioid dependency

Page 11: Pharmacology – Pot-pourri

• Precautions– Head trauma– Increased ICP

• Adverse reactions, SE– Confusion– Dysphoria– Hallucinations– Sedation– Sweating– Use with extreme

precautions in patient on MAO Inhibitors

Page 12: Pharmacology – Pot-pourri

• Route & dosage– 1 mg q 3-4 h prn

• How supplied– 1 mg/ml or 2 mg/ml in 1

ml preloads

Page 13: Pharmacology – Pot-pourri

Vicodin (Anexia)hydrocodone bitartrate w/

acetaminophen• Class

– Analgesic– Contains 5 mg narcotic, 500 mg

acetaminophen– Schedule III

• Indications– Analgesic for moderate to severe

pain

Page 14: Pharmacology – Pot-pourri

• Action– Binds to opiate

receptors– Acetaminophen

produces peripheral and central mechanisms

Page 15: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Head injuries

• Adverse reactions, SE– Respiratory depression– Sedation– Dizziness– Mental clouding– Acetaminophen overdose may

result in potentially fatal hepatic necrosis

Page 16: Pharmacology – Pot-pourri

• Route & dosage– 1 – 2 tablets q 4-

6 h prn PO– Total 24-hour

dose should not exceed 8 tablets

Page 17: Pharmacology – Pot-pourri

Demerol meperidine hydrochloride • Class

– Opioid analgesic– Schedule II

• Indications– Moderate or severe pain

• Action– Binds to opiate receptors in CNS

Page 18: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Head injury– Increased ICP

• Adverse reactions, SE– Seizures– Confusion, sedation– Hypotension– Constipation– N/V

Page 19: Pharmacology – Pot-pourri

• Route & dose– 50 – 100 mg slow IV,

SQ, IM • How supplied

– 10 mg/ml in 5 ml preload,

– 20 mg/ml, or 50 mg/ml in 5 ml preload

Page 20: Pharmacology – Pot-pourri

MS ContinMorphine Sulfate

• Class: Opioid analgesic• Indications

– Pulmonary edema– Pain – MI

• Action– Acts on opiate receptors to block

sensation of pain. Also causes peripheral vasodilation

Page 21: Pharmacology – Pot-pourri

• Contraindications– Head injury– Depressed respiratory drive– Hypotension

• Precautions: have intubation equipment and naloxone ready

Page 22: Pharmacology – Pot-pourri

• Adverse reactions, SE– Respiratory

depression– hypotension– Confusion– Sedation– constipation

Page 23: Pharmacology – Pot-pourri

• Dosage & Route– 2-10 mg slow IVP q 3 - 5

min. in 2 mg increments, titrated to relief

• How supplied– 10 mg/ml in 1 ml tubex

Page 24: Pharmacology – Pot-pourri

fentanyl• Class

– Opioid analgesic– Schedule II

• Indications– Analgesia

• Action– Binds to opiate receptors in CNS,

altering response to and perception of pain

Page 25: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Geriatrics– Diabetes– CNS tumors– alcoholism

Page 26: Pharmacology – Pot-pourri

• Adverse reactions, SE– Apnea– Laryngospasm

• Route & dosage– 50-100 mcg (0.05 – 1.0

mg) • How supplied

– 0.05 mg/ml in one ml preload or tubex

Page 27: Pharmacology – Pot-pourri
Page 28: Pharmacology – Pot-pourri

Nubainnalbuphine

• Class– Opioid analgesic

(Agonist/antagonist)• Indication

– Moderate to severe pain• Action

– Binds to opiate receptors– Alters perception of and response

to pain

Page 29: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity – Opioid

dependency• Precautions

– Head trauma– Increased ICP

Page 30: Pharmacology – Pot-pourri

• Adverse reactions, SE– Dizziness– Headache– Sedation– Dry mouth– N/V– Clammy feeling, sweating

Page 31: Pharmacology – Pot-pourri

• Route & dosage– 10 mg g 3-6 h (not to

exceed 20 mg) IV• How supplied

– 10 mg/ml in 1 and 10 ml vials or

– 20 mg/ml in 1 and 10 ml vials

– 1 ml preloads

Page 32: Pharmacology – Pot-pourri

Trexannaltrexone

• Class– Opiate receptor agonist

• Indications– Alcoholics to decrease

compulsive consumption– Detoxified addicts to stay opiate-

free

Page 33: Pharmacology – Pot-pourri

• Action– Competes for opiate receptors

• Contraindications– None noted

• Precautions– None noted

• Adverse reactions, SE– Abdominal cramps, – H/A– Depression– irritability

Page 34: Pharmacology – Pot-pourri

• Route & dosage– 25 mg tablets, PO;

repeat if no withdrawal sx in one hour

– Alcohol dependence; 50 mg qd PO

Page 35: Pharmacology – Pot-pourri

Narcannaloxone

• Class– Opioid antagonist

• Indication– Reversal of CNS depression and

respiratory depression 2ndary to opiate overdose

Page 36: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Cardiovascular

disease– Pregnancy

• Adverse reactions, SE– None in emergent

setting

Page 37: Pharmacology – Pot-pourri

• Route & dosage– 2 mg IV, SQ, IM,

ET, SL injection– Repeat prn

Page 38: Pharmacology – Pot-pourri

Nitronoxnitrous oxide

• Class– Analgesic

• Indications– Moderate to severe pain

• Action– Alters perception of pain– Decreases hypoxia

Page 39: Pharmacology – Pot-pourri

• Contraindications– Do not administer for

abdominal pain– Severe head injury

• Precautions– Must be self-

administered– N/V

Page 40: Pharmacology – Pot-pourri

• Route & dosage– Inhaled, blended

mixture of 50% nitrous oxide and 50% oxygen

– Effects dissipate within 2-5 min. after cessation of administ.

– Unit consists of oxygen & nitrous oxide cylinders, fed into blender; delivered to modified demand valve

Page 41: Pharmacology – Pot-pourri
Page 42: Pharmacology – Pot-pourri

BenzodiazepinesAnd a Benzodiazepine

Antagonist

Page 43: Pharmacology – Pot-pourri

We’ll talk about• Valium• Versed• Lorazepam

• & Flumazanil

Page 44: Pharmacology – Pot-pourri

Valiumdiazepam

• Class– Anticonvulsant– Sedative hypnotic agent– Skeletal muscle relaxant– Schedule IV

• Indications– seizures– Anxiety– Pre-paralytic– Pre-cardioversion– Alcohol withdrawal

Page 45: Pharmacology – Pot-pourri

• Action– Depresses CNS– Produces anterograde amnesia– Has anticonvulsant properties

Page 46: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity– Comatose patients– Pre-existing CNS depression

• Precautions– Hepatic dysfunction

Page 47: Pharmacology – Pot-pourri

• Adverse reactions, SE– Dizziness– Drowsiness– Lethargy

Page 48: Pharmacology – Pot-pourri

• Dosage & route• Seizures

– 5 – 10 mg IV; may repeat q 10 – 15 min. to total dose of 30 mg

• Precardioversion– 5 – 15 mg IV; 5 min.

before• Sedation

– 5 – 15 mg IV slowly

Page 49: Pharmacology – Pot-pourri

Versedmidazolam

• Class– Sedative/hypnotic (benzodiazepine)– Schedule IV

• Indications– Used to produce sedation

preoperatively– Antegrade & retrograde amnesia– Provides conscious sedation

Page 50: Pharmacology – Pot-pourri

• Action– Acts at many

levels of the CNS to produce generalized CNS depression; produces short-term sedation

Page 51: Pharmacology – Pot-pourri

• Contraindications– Shock– Pre-existing CNS depression

• Precautions– Pulmonary disease– CHF– Renal impairment– Severe hepatic impairment– Geriatric or debilitated

patients– children

Page 52: Pharmacology – Pot-pourri

• Adverse reactions, SE– Cardiac arrest– Apnea– Laryngospasm– Bronchospasm– Respiratory depression– Phlebitis at IV site

Page 53: Pharmacology – Pot-pourri

• Route & dosage– 0.5 – 1 mg slow IV or IM

initially – May repeat in 2-3 minutes

up to max dose of 5 mg.

• How supplied– 1 mg/ml in 2, 5, and 10 ml

vials and preloaded syringes

Page 54: Pharmacology – Pot-pourri

Ativanlorazepam

• Class– Anti-anxiety, sedative hypnotic – Schedule IV

• Indications– Anxiety– Preoperative sedation– Seizures

Page 55: Pharmacology – Pot-pourri

• Action– Depresses CNS– Decreases seizures

Page 56: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Myasthenia gravis

• Adverse reactions, SE– Apnea– Cardiac arrest– Dizziness– Drowsiness– lethargy

Page 57: Pharmacology – Pot-pourri

• Route & dosage– Amnesia

•2-4 mg slow IV – Seizures

•50 mcg IV•May repeat in 10-15 min.

– Sedation•2-4 mg slow IV or IM

– How supplied•2 mg/ml in 1 or 2 ml tubex

syringe

Page 58: Pharmacology – Pot-pourri

Romaziconflumazanil

• Class– Antidote (benzodiazepine

antagonist)• Indications

– Reverses the effect of benzodiazepines

• Action– Antagonizes CNS depressant effects

of benzodiazepines. Has no effect on CNS depression from other causes

Page 59: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Mixed CNS depressant

overdose– History of seizures– Head injury

• Adverse reactions, SE– Seizures– Dizziness– N/V

Page 60: Pharmacology – Pot-pourri

• Route & dosage– 0.2 – 0.5 mg IV – Maximum dose 3 mg

in a one hour period• How supplied

– 0.1 mg/ml in 5- and 10-ml vials

Page 61: Pharmacology – Pot-pourri
Page 62: Pharmacology – Pot-pourri

Barbiturates

Page 63: Pharmacology – Pot-pourri

Brevital• Class

– Ultra-short acting barbiturate– Schedule IV

• Indications– Cardioversion – Induction of anesthesia

• Action– Affects CNS

Page 64: Pharmacology – Pot-pourri

• Contraindications– None noted

• Precautions– Cardiac arrest

• Adverse reactions, SE– Hypotension– Laryngospasm– Seizures– shivering

Page 65: Pharmacology – Pot-pourri

• Route & dosage– 1-2 mg/kg IV

• How supplied– Brevital is a freeze-dried nonpyrogenic

mixture of methohexital sodium with anhydrous sodium carbonate as a buffer. A white crystalline powder, freely soluble in water.

– Prepare and use promptly.– Dilute with sterile water, 0.9% sodium

chloride, or D5W– Do not use LR– Mix vial (500 mg) with 50 ml of diluent

Page 66: Pharmacology – Pot-pourri

A different Anxiolytic

Page 67: Pharmacology – Pot-pourri

BuSparbuspirone

• Class– Anti-anxiety, sedative hypnotic

agent• Indication

– Anxiety• Action

– Binds to seratonin and dopamine receptors

Page 68: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Pts receiving other antianxiety

agents• Adverse reactions, SE

– dizziness, drowsiness, excitement, fatigue, H/A, insomnia, nervousness, weakness

– Blurred vision, nasal congestion– Chest pain, palpitations,

tachycardia

Page 69: Pharmacology – Pot-pourri

• Route & dosage– 10 – 15 mg PO

tid• How supplied

– tablets

Page 70: Pharmacology – Pot-pourri
Page 71: Pharmacology – Pot-pourri

Paralytics

Page 72: Pharmacology – Pot-pourri

We’ll talk about• Succinylcholine• Vecuronium• Rocuronium • Tracrium

Page 73: Pharmacology – Pot-pourri

Anectinesuccinylcholine

• Class– Anticholinergic drug– Currare– Neuromuscular blockade

• Indications– Facilitate ET intubation

Page 74: Pharmacology – Pot-pourri

• Action– Blocks acetylcholine

receptors at neuromuscular junctions

• Contraindications– Hypersensitivity

• Precautions– Must be skilled in

intubation

Page 75: Pharmacology – Pot-pourri

• Adverse reactions, SE– Apnea– Arrhythmias– Malignant hyperthermia – Vomiting– Aspiration– Bradycardia– Hypertension– Concurrent

administration with physostigmine intensifies paralysis

Page 76: Pharmacology – Pot-pourri

• Route & dosage– 1.5 mg/kg IV– Onset ~ 1 min.– Recovery, 4-6 min.– OR– 3-4 mg/kg IM (max. dose 150 mg)– Onset 2 – 3 min.

Page 77: Pharmacology – Pot-pourri

• How supplied– 20 mg/ml in 10 ml vial

• Note:– Fasciculations start at eyelids, jaw –

progresses to limbs, abdomen, then diaphragm and intercostal muscles.

– Succs does NOT affect consciousness

Page 78: Pharmacology – Pot-pourri

• Procedure– Preoxygenate– Prepare equipment– Atropine, 0.01 – 0.02 mg.kg (Peds or

bradycardia)– Lidocaine 1 mg/kg (Head injury)– Valium or Versed – Succinylcholine, IV– Stop ventilations– Sellick’s maneuver until intubated– When fasciculations stop, check paralysis– Intubate!– If Succs starts to wear off, consider

Vecuronium 0.1 mg/kg IVP; may repeat 0.05 mg/kg

Page 79: Pharmacology – Pot-pourri

Vecuronium • Class

– Non-depolarizing neuromuscular blocking agent

• Indications– Intubation

• Action– Binds to acetylcholine at motor

receptors– Has little histamine release

Page 80: Pharmacology – Pot-pourri

• Contraindications– None in the emergency setting

• Precautions– Increased blockade with

bacitracin, lidocaine, verapamil• Adverse reactions, SE

– Malignant hyperthermia

Page 81: Pharmacology – Pot-pourri

• Route & dosage– 0.15 mg/kg IV– Onset: 2-3 minutes– Duration: 45 minutes

• How supplied

Page 82: Pharmacology – Pot-pourri

Zemuronrocuronium bromide

• Class– Non-depolarizing neuromuscular

blocking agent with a rapid to intermediate onset

• Indications– Intubation

• Action– Competes for cholinergic receptors at

the motor end-plate

Page 83: Pharmacology – Pot-pourri

• Contraindications– None in the emergency setting

• Precautions– Myasthenia Gravis

• Adverse reactions, SE– H/A– Hypertension or– Hypotension

Page 84: Pharmacology – Pot-pourri

• Route & dosage– 0.6-1.2 mg/kg IV (90mg)– Onset: 1-2 minutes– Duration: 30 minutes

• How supplied– 10 mL vials (10 mg/mL)

Page 85: Pharmacology – Pot-pourri
Page 86: Pharmacology – Pot-pourri

Tracriumatracurium besylate

• Class– Nuromuscular blocking agent

• Indications– Intubation

• Action– Competes with acetylcholine for

receptors at neuromuscular junction

Page 87: Pharmacology – Pot-pourri

• Contraindications– Myasthenia gravis

• Precautions– Increased neuromuscular

blockade with lidocaine, bacitracin, verapamil

• Adverse reactions, SE– Does NOT affect

consciousness– Arrhythmias

Page 88: Pharmacology – Pot-pourri

• Route & dosage– 0.5 mg/kg IV– Duration 20-30 min.

• How supplied• 50 mg/2 ml tubex or vial

Page 89: Pharmacology – Pot-pourri
Page 90: Pharmacology – Pot-pourri

Miscellaneous drugs

Page 91: Pharmacology – Pot-pourri

We’ll talk about• Aspirin (again)• Acetaminophen• Activated charcoal• Decadron• D50• Diphenhydramine• Epinephrine

1:1000• Inapsine• Glucagon• Glucose, Oral• Heparin

• Haloperidol• Ipecac• Mannitol• Solu-Medrol• Oxytocin• Phenergan• Pralidoxime• Streptokinas

e• Thiamine• Terbutaline

Page 92: Pharmacology – Pot-pourri

Aspirin (acetysalicylate acid,

ASA)• Class

– Salicylate• First synthesized in mid-19th century• Indication

– Inflammatory disorders– Fever– TIA– MI

Page 93: Pharmacology – Pot-pourri

• Action– Produces analgesia – Reduces inflammation and fever by

inhibiting the synthesis of prostoglandins

– Decreases platelet aggregation

Page 94: Pharmacology – Pot-pourri

New Info!New England Journal of Medicine,

3/05• Men 50 y/o or more

(no clinical evidence of coronary disease).

• ASA - Risk of MI 44% less

• No significant effect on risk of stroke and no effect on mortality from cardiovascular causes

• Women 65 y/o or more (no history of cardiovascular disease)

• ASA - No significant effect on risk of MI or risk of death from cardiovascular causes

• BUT 24% reduction in risk of ischemic stroke and 17% reduction in stroke risk overall

Page 95: Pharmacology – Pot-pourri

Conclusion of study• Women < 65 y/o• Reasonable to avoid prescribing

low-dose aspirin (75-100mg) as a preventative measure for coronary disease

• Rx for stroke – left to pt and Dr

Page 96: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity – Bleeding disorders or

thrombocytopenia• Precautions

– GI bleeds or ulcers– Chronic alcohol use/abuse– Severe renal disease– Viral infections – Pregnancy

Page 97: Pharmacology – Pot-pourri

• Adverse reactions, SE– GI bleeding– Anaphylaxis– Laryngeal edema– Dyspepsia, epigastric distress– Heartburn, nausea

Page 98: Pharmacology – Pot-pourri

• Dosage & route– Pain, Fever

•PO, Rectal– 325 – 500 mg q 3 h OR– 325 – 650 mg q 4 h– Not to exceed 4 g/day

– Cardiac chest pain•PO•81 mg x 3 chewable children's

aspirin (243 mg)– (UNLESS TAKING COUMADIN)

• How supplied– Children's aspirin, 81 mg tablets– Aspirin 325 - 500 mg tablets

Page 99: Pharmacology – Pot-pourri

Tylenolacetaminophen, APAP

• Class– Antipyretic agent

• Indications– Mild pain– Fever

• Action– Inhibits synthesis of prostaglandins

that serve as mediators of pain and fever

– Has no significant anti-inflammatory properties

Page 100: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Hepatic disease, renal

disease• Adverse reactions, SE

– Hepatic failure

Page 101: Pharmacology – Pot-pourri

• Route & dosage– PO (adults)

•325 – 650 mg q 4 h– Rectal (children & infants)

•80 mg q 4-6 h (infants 3 – 11 mo children 1 – 3 y/o)

– How supplied•500 mg tablets•80 mg suppositories

Page 102: Pharmacology – Pot-pourri

Acti-Char, Actidose activated charcoal

• Class– Antidote

• Indications– Acute management of many

poisonings following emesis/lavage

• Action– Binds drugs and chemicals in the

GI tract

Page 103: Pharmacology – Pot-pourri

• Contraindications– None known

• Precautions– Cyanide, corrosive, ethanol,

petroleum, organic solvent or iron poisoning

• Adverse reactions, SE– Black stool

Page 104: Pharmacology – Pot-pourri

• Route & dosage– Adults, PO – 25 – 100 g– Children 1-12 y/o, PO – 25-50 g– Children < 1 y/o, PO 1 g/kg

• How supplied– Oral suspension with sorbitol, 15-

50 g in 120-140 ml

Page 105: Pharmacology – Pot-pourri

Decadrondexamethasone sodium phosphate

• Class– Short acting gluco-corticoid

• Indications– Cerebral edema

• Action– Suppresses inflammation

Page 106: Pharmacology – Pot-pourri

• Contraindications– Active untreated

infections– Lactation

• Precautions– Chronic treatment – Children

Page 107: Pharmacology – Pot-pourri

• Adverse reactions, SE– Peptic ulcers– Thromboembolism – Depression – Euphoria– Muscle wasting– Cushingoid appearance– Osteoporosis

Page 108: Pharmacology – Pot-pourri

• Route & Dosages– 10 – 100 mg IVP

•10 mg initially, then 4 – 6 mg q 6 hr for 2-4 days then taper off over 5-7 days

• How supplied– 10 mg/ml in 10 ml vial

Page 109: Pharmacology – Pot-pourri

D50Dextrose 50%

• Class– Caloric agent (carbohydrate)

• Indication– Hypoglycemia– Altered mentation when history

unobtainable

Page 110: Pharmacology – Pot-pourri

• Contraindications– Allergies to corn or corn products

• Precautions– Chronic alcoholics– Severe malnutrition

Page 111: Pharmacology – Pot-pourri

• Adverse reactions, SE– None if blood glucose

is less than 80 mg/dcL– Venous irritation

• Interactions:– Will alter requirements

for insulin

Page 112: Pharmacology – Pot-pourri

• How Supplied:– 25 gm in 50 ml (50% dextrose)– 12.5 gm in 50 ml (25% dextrose)

• Route & Dosage– IV: Adults

•20-50 ml of 50% solution slow infusion

– IV: Infants and neonates•250-500 mg/kg/dose (as 25% dextrose)

Page 113: Pharmacology – Pot-pourri

• Important note– Assess IV site frequently for

extravasation; will cause tissue necrosis; immediately stop administration of drug

– Check for free blood return into syringe several times during administration

Page 114: Pharmacology – Pot-pourri

Benadryldiphenhydramine

• Class– Antihistamine

• Indication– Relief of allergic symptoms– Anaphylaxis– Parkinsons disease– Dystonic reactions

Page 115: Pharmacology – Pot-pourri

• Action– Competes for histamine receptor

sites

– Blocks histamine

– Significant CNS depressant properties

Page 116: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity– Acute asthmatic episode

• Precautions– Geriatrics– Severe liver disease

Page 117: Pharmacology – Pot-pourri

• Adverse reactions, SE– Drowsiness– Anorexia– Dry mouth

• Route & dosage– 10-50 mg IVP q 2-3 h

• How supplied– 5 mg/ml in 10 ml preload

or tubex

Page 118: Pharmacology – Pot-pourri
Page 119: Pharmacology – Pot-pourri

Inapsinedroperidol

• Class– Tranquilizer– Antiemetic

• Indications– Sedation of combative

patients to facilitate restraint

– N/V

Page 120: Pharmacology – Pot-pourri

• Action– Similar to haloperidol, alters

action of dopamine in CNS– Allays apprehension and

provides a state of mental detachment and indifference while maintaining a state of reflex alertness.

Page 121: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity– CNS depression– Severe liver disease or cardiac

disease• Precautions

– Hypotension may occur; have fluids available

– Elderly

Page 122: Pharmacology – Pot-pourri

•Adverse reactions, SE•Seizures •Extrapyramidal reactions

•Hypotension•tachycardia

Page 123: Pharmacology – Pot-pourri

• Route & Dosage– Chemical restraint

•0.625 – 10 mg slow IV or IM (Usual dose 2.5 – 5.0 mg)

•Onset 3 – 10 min.•Peak 30 min.•Duration 2-4 hr.

– Antiemetic•0.5 – 1 mg q 4 hr

How supplied– 2.5 mg/ml in 2 ml preload

Page 124: Pharmacology – Pot-pourri

Epinephrine 1:1,000• Class

– Adrenergic agonist– Vasopressor

• Indications– Management of reversible airway disease– Management of severe allergic reaction– Cardiac arrest

Page 125: Pharmacology – Pot-pourri

• Action– Affects both beta1 and beta2

receptor sites– Has alpha1 properties– Produces bronchodilation– Vasoconstriction– Inhibits release of mediators

from mast cells

Page 126: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Cardiac disease– Hypertension

Page 127: Pharmacology – Pot-pourri

• Adverse reactions, SE– Nervousness– Restlessness– Tremor– Angina– Arrhythmias– Hypertension

Page 128: Pharmacology – Pot-pourri

• Route & dosage– Anaphylactic/ Acute Asthma:– SQ or IM 0.1 – 0.5 mg q 10-15

min.• How supplied

– 1 mg/ml in 1 mg tubex or preload

Page 129: Pharmacology – Pot-pourri

Glucagon• Class

– Hormone• Indications

– Acute management of severe hypoglycemia

– Antidote to Beta-adrenergic blocking agent, calcium channel blockers

Page 130: Pharmacology – Pot-pourri

• Action– Stimulates hepatic production of

glucose from glycogen stores– Relaxes smooth muscle of GI

tract– Has positive inotropic and

chronotropic effects

Page 131: Pharmacology – Pot-pourri

Contraindications– Hypersensitivity to

beef or pork protein

• Precautions– Pheochromocytoma

Page 132: Pharmacology – Pot-pourri

• Adverse reactions & side effects– N/V

• Drug Interactions– Large doses may inhance

effects of Warfarin

Page 133: Pharmacology – Pot-pourri

• Route & dosage– Hypoglycemia: 1 mg IV or IM– Antidote to Beta-blockers: 0.25–

2mg IV– Antidote to Calcium channel

blockers: 2 mg IV• How supplied

– 1 mg glucagon in powder for injection with diluent of glycerin & small amount of hydrochloric acid

– Mix immediately before administration

Page 134: Pharmacology – Pot-pourri

Oral Glucose

• Class– Glycemic agent

• Indications– Hypoglycemia

• Action– Increases blood glucose

Page 135: Pharmacology – Pot-pourri

• Contraindications– Loss of gag reflex

• Precautions– Decreased mentation

• Route & dosage– 25 gm glucose, oral

Page 136: Pharmacology – Pot-pourri

Haldolhaloperidol

• Class – Antipsychotic agent

• Indications– Acute and chronic psychosis– Tourette’s syndrome– N/V from surgery or

chemotherapy

Page 137: Pharmacology – Pot-pourri

• Action– Alters effect of dopamine in CNS– Has anticholinergic, alpha-

adrenergic blocking activity

Page 138: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Geriatrics– Cardiac disease

Page 139: Pharmacology – Pot-pourri

• Adverse reactions, SE– Seizures– Blurred vision, dry eyes– Constipation, dry mouth

• Route & dosage– 0.5 – 5 mg IV or IM

• How supplied– 5 mg/ml in 1-ml tubex

Page 140: Pharmacology – Pot-pourri

Heparin• Class

– Anticoagulant• Indication

– Thromboembolic disorders• Action

– Potentiates the inhibitory effect of antithrombin

Page 141: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity– Uncontrolled bleeding

• Precautions– Spinal cord or brain

injury– Bleeding disorder– Women > 60– Severe uncontrolled

hypertension– Hemorrhagic stroke

Page 142: Pharmacology – Pot-pourri

• Adverse reactions, SE– Bleeding– Anemia– Thrombocytopenia

• Route & dosage– Anticoagulation

•10,000 u IV followed by 5,000 – 10,000u q 4-6 h

– Continuous infusion•20,000 – 40,000u infused over 24 h

• How supplied– 5,000 u/ml in vial

Page 143: Pharmacology – Pot-pourri

Ipecac• Class

– Antidote• Indications

– Induce vomiting in early managment of OD/poisoning

• Action– Stimulates chemoreceptor trigger

zone in CNS and irritates gastric mucosa

Page 144: Pharmacology – Pot-pourri

• Contraindications– Decreased mentation– Inebriated– Seizing patient

• Precautions– Pregnancy, lactation, children < 6

mo

Page 145: Pharmacology – Pot-pourri

• Adverse reactions, SE– Myocarditis– Arrhythmias

• Route & dosage– PO (adults) 15-30 ml

may repeat at 15 ml in 20-30 min

– PO (children) 15 ml may repeat in 20-30 min

• How supplied– Syrup

•15 ml or 30 ml containers

Page 146: Pharmacology – Pot-pourri

Mannitol 20%• Class

– Diuretic agent• Indications

– Increased ICP• Action

– Increases osmotic pressure of glomerular filtrate, inhibits reabsorption of water and electrolytes

Page 147: Pharmacology – Pot-pourri

• Contraindications– Dehydration– Active intracranial bleeding

• Precautions– Pregnancy, lactation

• Adverse reactions, SE– Transient volume expansion

Page 148: Pharmacology – Pot-pourri

• Route & dosage– IV, 1-2 g/kg slow IVP

(over 30 min.)

• How supplied– 2 g in 20 ml vial

Page 149: Pharmacology – Pot-pourri

Solu-Medrolmethylprednisolone sodium

succinate• Class:

– An intermediate-acting glucocorticoid– Anti-inflammatory– Immunosuppressant

• Indications:– Management of acute spinal cord injury– Used systemically for chronic diseases

• Inflammatory• Allergic• Autoimmune disorders

Page 150: Pharmacology – Pot-pourri

• Action– Stimulates the synthesis of enzymes

needed to decrease the inflammatory response. Suppresses the immune system by reducing activity and volume of lymphatic system, and possibly reduces reactivity of tissue to antigen-antibody interactions

Page 151: Pharmacology – Pot-pourri

• Contraindications– Active untreated infections – Systemic fungal infections– Don’t give live virus vaccines

if patient on methylprednisolone

• Precautions– GI ulcerations– Renal disease– Hypertension

Page 152: Pharmacology – Pot-pourri

• Adverse reactions and side effects– Depression, euphoria

– Hypertension

– Nausea, anorexia

– Decreased wound healing

– Muscle wasting

– Osteoporosis

Page 153: Pharmacology – Pot-pourri

• Route and dosage– Spinal cord injury

•30 mg/kg over 15 min. initially, then 45 min. later initiate continuous infusion of 5.4 mg/kg/hr for 23 hrs.

• How supplied– 4 mg/ml, 10 mg/ml, 20 mg/ml vial

Page 154: Pharmacology – Pot-pourri
Page 155: Pharmacology – Pot-pourri

PitocinOxytocin

• Class– Hormone

• Indication– Induction of labor at term– Postpartum control of bleeding

Page 156: Pharmacology – Pot-pourri

•Action

– Stimulates smooth muscle

– Has vasopressor and

antidiuretic effects

Page 157: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– First and second stage of

labor• Adverse reactions, SE

– Coma– Seizure – Intracranial hemorrhage– Fetal asphyxia– Painful contractions

Page 158: Pharmacology – Pot-pourri

• Route & dosage– Induction of labor: 0.5 – 2

milliunits/min; increase by 1-2 milliunits/min q 15-60 min to result

– Postpartum hemorrhage•10 units infused at 20-40

milliunits/min.

• How supplied– 10 units/ml in 0.5 and 1 ml ampules– 1 ml preloads

Page 159: Pharmacology – Pot-pourri

PhenerganPromethazine

• Class– Antiemetic agent– Antihistamine – Sedative hypnotic

• Indications– Preoperative sedation – Allergic conditions– Motion sickness

Page 160: Pharmacology – Pot-pourri

• Action– Blocks histamine effects

– Inhibitory effect on chemoreceptor trigger zone in medulla

– Significant anticholinergic activity

Page 161: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Hypertension– Sleep apnea– Epilepsy

• Adverse reactions, SE– Neuroleptic malignant syndrome– Confusion, disorientation,

sedation

Page 162: Pharmacology – Pot-pourri

• Route & dosage– Antihistamine: IV, IM, PR,

25 mg; repeat in 2 hr– Sedation: IV, IM, PR, 25-

50 mg• How supplied

– 25 mg/ml in 1 ml ampules and 1 and 10 ml vials

– Suppositories: 12.5 mg, 25 mg, 50 mg.

Page 163: Pharmacology – Pot-pourri

Protopam Chloride, 2 PAM

Pralidoxime Cl• Class

– Antidote– Anticholinesterase poisoning

inhibitor• Indication

– After Atropine in severe cases of organophosphate poisoning•Muscle twitching, paralysis

• Action– Reactivates cholinesterase

Page 164: Pharmacology – Pot-pourri

• Contraindications– Inorganic phosphate

poisoning

• Precautions– Tachycardia, laryngospasm,

muscle rigidity with rapid infusion

– Reduce dosage for patient with impaired renal function

Page 165: Pharmacology – Pot-pourri

• Adverse reactions, SE– Dizziness, headache– Tachycardia– Nausea– Blurred vision

Page 166: Pharmacology – Pot-pourri

• Route & dosage– 1 – 2 g SLOW IV bolus or– IV infusion over 30-60 min. after

administration of Atropine– For infusion; mix 1 g in 250 ml NS

• How supplied– 1 g/20 ml vial– Must be reconstituted with 20 ml

sterile water

Page 167: Pharmacology – Pot-pourri

Streptokinase• Class

– Thrombolytic agent• Indications

– AMI < 12 h old– Pulmonary emboli– DVT

• Action– Convert plasminogen to plasmin;

degrades fibrin

Page 168: Pharmacology – Pot-pourri

• Contraindications– Active internal bleed– CVA– Recent CNS trauma or

surgery– Severe uncontrolled

hypertension• Precautions

– Surgery with in 10 days– Trauma– GI or GU bleeding– Recent arterial puncture

Page 169: Pharmacology – Pot-pourri

• Adverse reactions, SE– Intracranial hemorrhage– GI bleeding– Retroperitoneal bleeding– GU tract bleeding– Anaphylaxis– Reperfusion arrhythmias

Page 170: Pharmacology – Pot-pourri

• Route & dosage– MI

•1.5 million IU infused over 60 min.

– DVT, PE•250,000 IU loading dose over 30

min., followed by 100,000 IU/h for 24 – 72 h

Page 171: Pharmacology – Pot-pourri

• How supplied– Powder for injection; 250,000

IU/vial, or 1,500,000 IU/vial– Reconstitute with 5 ml NaCl or

D5W (direct to side of vial)– Swirl gently; do not shake– Dilute further with NaCl for total

volume of 45-500 ml – 45 ml for MI– 90 ml for DVT

• Administer through filter

Page 172: Pharmacology – Pot-pourri

Thiamine• Class

– Vitamin B-1• Indications

– Treatment of thiamine deficiency (Beriberi)

– Prevention of Wernicke’s encephalopathy

– Dietary supplement in pt with GI disease, alcoholism, or cirrhosis

Page 173: Pharmacology – Pot-pourri

• Actions– Required for carbohydrate metabolism

• Distribution– Widely distributed

• Metabolism & excretion– Metabolized by the liver.– Excess amounts excreted unchanged

by kidneys

Page 174: Pharmacology – Pot-pourri

• Half-life– Unknown

• Contraindications– None in prehospital setting

• Precautions– Wernicke’s encephalopathy

•Condition may be worsened unless thiamine is administered before glucose.

Page 175: Pharmacology – Pot-pourri

• Adverse reactions & side effects– None in prehospital setting

• Interactions– May inhance

neuromuscular blocking agents

Page 176: Pharmacology – Pot-pourri

• How supplied– 100 mg/ml in 1 ml ampules and

prefilled syringes

• Route and dosage– 100 mg IVP (may be given IM)

Page 177: Pharmacology – Pot-pourri

Brethineterbutaline

• Class– Bronchodilator

• Indication– Asthma– COPD– Preterm labor

• Action– Results in accumulation of cyclic adenosine

monophosphate at beta-adrenergic receptors

Page 178: Pharmacology – Pot-pourri

• Contraindications– Hypersensitivity

• Precautions– Near-term pregnancy

• Adverse reactions, SE– Paradoxical bronchospasm– Nervousness,

restlessness, tremor

Page 179: Pharmacology – Pot-pourri

• Route & dosage– Preterm labor: IV, 10

mcg/min., increase by 5 mcg/min until contractions stop.

• How supplied– 1 mg/ml in 1 ml tubex

Page 180: Pharmacology – Pot-pourri